Journal article · 2020 · Open access
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal
Scientific Reports, 10(1), 8907 · Published 1 June 2020 · DOI 10.1038/s41598-020-65553-5
In brief
“Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal” is a 2020 journal article by Mamadou Alpha Diallo and 14 co-authors, published in Scientific Reports. OpenAlex counts 70 citations as of 19 November 2026, which puts it in the top 6% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Scientific Reports.
- Citations
- 70
- Most cited in
- 2021 (25)
- Field-weighted impact
- 7.50
- References
- 48
- Authors
- 15
Abstract
In 2006, Senegal adopted artemisinin-based combination therapy (ACT) as first-line treatment in the management of uncomplicated malaria. This study aimed to update the status of antimalarial efficacy more than ten years after their first introduction. This was a randomized, three-arm, open-label study to evaluate the efficacy and safety of artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ) and dihydroartemisinin-piperaquine (DP) in Senegal. Malaria suspected patients were screened, enrolled, treated, and followed for 28 days for AL and ASAQ arms or 42 days for DP arm. Clinical and parasitological responses were assessed following antimalarial treatment. Genotyping (msp1, msp2 and 24 SNP-based barcode) were done to differentiate recrudescence from re-infection; in case of PCR-confirmed treatment failure, Pfk13 propeller and Pfcoronin genes were sequenced. Data was entered and analyzed using the WHO Excel-based application. A total of 496 patients were enrolled. In Diourbel, PCR non-corrected/corrected adequate clinical and parasitological responses (ACPR) was 100.0% in both the AL and ASAQ arms. In Kedougou, PCR corrected ACPR values were 98.8%, 100% and 97.6% in AL, ASAQ and DP arms respectively. No Pfk13 or Pfcoronin mutations associated with artemisinin resistance were found. This study showed that AL, ASAQ and DP remain efficacious and well-tolerated in the treatment of uncomplicated P. falciparum malaria in Senegal.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Diallo, M. A., YADE, M. S., Ndiaye, Y. D., Diallo, I., Diongue, K., Sy, S. A., Sy, M., Seck, M. C., Ndiaye, M., Dièye, B., Gomis, J. F., Sow, D., Dème, A. B., Badiane, A. S., & Ndiaye, D. (2020). Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Scientific Reports, 10(1), 8907. https://doi.org/10.1038/s41598-020-65553-5
MLA 9
Diallo, Mamadou Alpha, et al. “Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.” Scientific Reports, vol. 10, no. 1, 2020, p. 8907. https://doi.org/10.1038/s41598-020-65553-5.
Chicago
Diallo, Mamadou Alpha, Mamadou Samb YADE, Yaye Dié Ndiaye, Ibrahima Diallo, Khadim Diongue, Saidou Abdoul Sy, Mouhamad Sy, et al. 2020. “Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.” Scientific Reports 10 (1): 8907. https://doi.org/10.1038/s41598-020-65553-5.
Harvard
Diallo, M. A. et al. (2020) ‘Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal’, Scientific Reports, 10(1), p. 8907. doi:10.1038/s41598-020-65553-5.
IEEE
M. A. Diallo et al., “Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal,” Scientific Reports, vol. 10, no. 1, p. 8907, 2020, doi: 10.1038/s41598-020-65553-5.
BibTeX
@article{diallo2020efficacy,
title = {{Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal}},
author = {Diallo, Mamadou Alpha and YADE, Mamadou Samb and Ndiaye, Yaye Dié and Diallo, Ibrahima and Diongue, Khadim and Sy, Saidou Abdoul and Sy, Mouhamad and Seck, Mame Cheikh and Ndiaye, Mouhamadou and Dièye, Baba and Gomis, Jules François and Sow, Djiby and Dème, Awa B. and Badiane, Aïda Sadikh and Ndiaye, Daouda},
journal = {Scientific Reports},
year = {2020},
volume = {10},
number = {1},
pages = {8907},
doi = {10.1038/s41598-020-65553-5},
url = {https://doi.org/10.1038/s41598-020-65553-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 3 | |
| 2021 | 25 | |
| 2022 | 7 | |
| 2023 | 13 | |
| 2024 | 14 | |
| 2025 | 6 | |
| 2026 | 2 |
Its field-weighted citation impact is 7.50: it has been cited 7.50 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- artemisinin-based combination therapy
- uncomplicated malaria
- Plasmodium falciparum
- artemether-lumefantrine
- artesunate-amodiaquine
- dihydroartemisinin-piperaquine
- treatment efficacy
- treatment safety
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Diallo, M. A., YADE, M. S., Ndiaye, Y. D., Diallo, I., Diongue, K., Sy, S. A., Sy, M., Seck, M. C., Ndiaye, M., Dièye, B., Gomis, J. F., Sow, D., Dème, A. B., Badiane, A. S., & Ndiaye, D. (2020). Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Scientific Reports, 10(1), 8907. https://doi.org/10.1038/s41598-020-65553-5
How many times has this paper been cited?
70 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Scientific Reports: sign in and open the PDF from this page.
Who wrote this paper?
Mamadou Alpha Diallo, Mamadou Samb YADE, Yaye Dié Ndiaye, Ibrahima Diallo, Khadim Diongue, Saidou Abdoul Sy, Mouhamad Sy, Mame Cheikh Seck, Mouhamadou Ndiaye, Baba Dièye, Jules François Gomis, Djiby Sow and 3 more.
What is the DOI of this paper?
10.1038/s41598-020-65553-5, permanently at https://doi.org/10.1038/s41598-020-65553-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.